Tirosint Cost in Oregon 2026: Cash Price, Insurance, Medicaid and Cheaper Alternatives

What Does Tirosint Actually Cost in Oregon in 2026?

The average cash-pay price for Tirosint at Oregon retail pharmacies in 2026 is approximately $230 per month. That figure applies to the standard 30-capsule supply and holds fairly consistently across chains like Walgreens, Rite Aid, and Fred Meyer pharmacy locations, as well as independent Oregon pharmacies. Tirosint-SOL (the liquid formulation) sits in a similar price band.

No FDA-approved generic levothyroxine gel capsule exists as of mid-2025, which is why the price stays high. Standard levothyroxine tablets (generic) cost as little as $4 to $10 per month at the same pharmacies, so the gel-capsule premium is real and substantial. Patients switching to Tirosint from generic tablets are often surprised by this jump.

Prices quoted on GoodRx and similar platforms for Oregon zip codes range from roughly $195 to $245 depending on the specific pharmacy and the coupon applied. These coupons cannot be combined with insurance, including Medicare Part D or Oregon Health Plan, so patients must choose one or the other at the point of sale.

IBSA Pharma, the manufacturer, sets the wholesale acquisition cost (WAC) at approximately $230 per 30-unit supply. Because Tirosint lacks a generic competitor in its formulation class, pharmacy benefit managers have little negotiating use, and that WAC tends to pass through to cash-pay patients with minimal discount FDA label for Tirosint, NDA 022461.

Why Would a Clinician Prescribe Tirosint Instead of a Generic Tablet?

Tirosint contains only four ingredients: levothyroxine sodium, gelatin, glycerin, and water. Generic levothyroxine tablets contain acacia, confectioner's sugar, lactose, magnesium stearate, povidone, and talc, among others. Patients with lactose intolerance, gluten sensitivity, dye allergies, or specific GI conditions can absorb the gel capsule more consistently.

Vita et al. (Endocrine, 2014) studied 31 patients with hypothyroidism and either Helicobacter pylori infection or autoimmune atrophic gastritis who were switched from standard levothyroxine tablets to the liquid formulation. TSH normalized in significantly more patients on the liquid preparation, and mean TSH dropped from 4.1 mIU/L to 1.3 mIU/L over 6 months Vita et al., 2014. That is a clinically meaningful shift for a population that routinely under-absorbs tablet formulations.

Absorption is the key issue. Tablets depend on gastric pH and dissolution kinetics. The gel capsule bypasses much of that variability because the drug is already dissolved in glycerin. Patients on proton pump inhibitors (PPIs), calcium carbonate, or iron supplements, all of which reduce levothyroxine tablet absorption, may absorb the gel capsule more reliably. A randomized crossover study published in the Journal of Clinical Endocrinology and Metabolism found that the liquid formulation co-administered with coffee showed no significant absorption interference, whereas the tablet form showed a 36% reduction in absorption under the same conditions Benvenga et al., 2013.

Coffee with breakfast. That single daily habit can derail tablet-based thyroid replacement.

Does Oregon Medicaid (Oregon Health Plan) Cover Tirosint?

Oregon Health Plan (OHP) covers Tirosint with a prior authorization (PA) for patients with documented malabsorption or a condition that impairs levothyroxine tablet absorption. The PA requirement exists because generic levothyroxine tablets are covered at essentially no cost to the member, making Tirosint a non-preferred brand.

To obtain PA approval through OHP, a prescribing clinician generally must document one or more of the following:

• A diagnosis associated with impaired GI absorption (celiac disease, short bowel syndrome, atrophic gastritis, or post-bariatric surgery status).
• Documented failure to achieve target TSH on at least one trial of generic levothyroxine tablets at an adequate dose.
• A clinical rationale explaining why the tablet formulation is pharmacologically inappropriate for the patient.

OHP PA decisions are typically returned within 72 hours for standard requests and within 24 hours for urgent clinical situations. If the PA is denied, the prescriber can file a first-level appeal with clinical documentation, and patients have the right to request an Independent External Review through the Oregon Insurance Division if commercial carrier denials persist.

The American Thyroid Association (ATA) 2014 Guidelines on the treatment of hypothyroidism state: "In patients in whom absorption of levothyroxine may be impaired, liquid levothyroxine preparations may be considered as an alternative to tablet formulations" Jonklaas et al., ATA 2014. That language is the clinical foundation most Oregon prescribers use when writing PA letters.

Dual-eligible patients (Medicare and Medicaid) may find that Medicare Part D governs the drug benefit. Tirosint's coverage under Part D varies by plan formulary; most plans place it on Tier 3 or Tier 4, with copays ranging from $45 to $95 per month after deductible.

Which Private Insurance Plans Cover Tirosint in Oregon?

Coverage varies significantly. In Oregon's commercial market, major carriers including Providence Health Plan, Moda Health, PacificSource, and Regence BlueCross BlueShield of Oregon each maintain their own formulary tiers for levothyroxine products.

Most of these plans place generic levothyroxine tablets on Tier 1 (preferred generic) at $0 to $10 per fill. Tirosint typically lands on Tier 3 (non-preferred brand) or Tier 4 (specialty), translating to copays of $50 to $120 per month after deductible on many Oregon commercial plans. Some high-deductible health plans (HDHPs) require patients to meet the full deductible, often $1,500 to $3,000, before any drug coverage kicks in.

Patients should call the Member Services number on the back of their insurance card and ask specifically: "Is Tirosint (NDC prefix 67979) on my formulary, and what tier?" Getting that answer in writing via the Explanation of Benefits (EOB) or a formulary lookup document matters when the pharmacy charges more than expected.

The IBSA Tirosint Savings Card is available to commercially insured patients who meet income and eligibility criteria. Per IBSA's published program terms, eligible patients may pay as little as $0 per month for up to 12 fills. The card does not apply to government-funded insurance including Medicare, Medicaid, TRICARE, or VA benefits. Oregon patients can enroll at IBSA's patient savings portal or ask their pharmacy to run the card at the point of sale.

Is Compounded Levothyroxine Legal in Oregon, and How Affordable Is It?

Yes. Oregon allows licensed 503A compounding pharmacies to prepare levothyroxine in liquid or gel-capsule form for individual patients with a valid prescription from a licensed prescriber. This is legal under both Oregon state pharmacy law and federal 503A provisions of the Drug Quality and Security Act.

503A pharmacies compound for individual patients based on a practitioner's prescription. They are regulated by the Oregon State Board of Pharmacy and must comply with USP Chapter 795 standards for non-sterile compounding. They cannot manufacture large batches for general sale, which distinguishes them from 503B outsourcing facilities.

The cost difference is striking. Compounded levothyroxine liquid or gel capsules from Oregon 503A pharmacies typically run from $15 to $40 per month, and some compounding pharmacies that work with telehealth platforms offer the product at or near $0 per month as part of bundled membership pricing. That is a reduction of $190 or more compared to brand-name Tirosint at cash price.

Clinically, the key question is bioequivalence. FDA-approved Tirosint has published pharmacokinetic data and standardized manufacturing. Compounded levothyroxine preparations are not FDA-approved and lack the same level of potency verification across batches. The ATA and the American Association of Clinical Endocrinology (AACE) have both noted that compounded thyroid preparations should be used when a commercially available product does not meet a patient's clinical needs, and that TSH should be monitored closely after any formulation change Garber et al., AACE/ATA 2012.

A reasonable clinical protocol: check TSH 6 to 8 weeks after switching from Tirosint to a compounded equivalent, and again after any compounding pharmacy or batch change.

HealthRX Oregon Tirosint Cost Decision Framework

Use this stepwise approach when a patient in Oregon needs levothyroxine gel-capsule or liquid formulation:

1. Confirm clinical indication. Document the specific reason tablets are inadequate (GI disorder, absorption interference, excipient sensitivity). This documentation is required for any PA and is good clinical practice regardless.
2. Check insurance formulary. Run a real-time formulary check or call the plan. Tier 3 or 4 means a PA or step therapy is likely required.
3. OHP patients: file PA immediately. Attach the Vita 2014 or Benvenga 2013 data to the PA letter. Approval rates improve with peer-reviewed citations.
4. Commercial patients with Tier 3/4 placement: apply the IBSA savings card. This brings cost to near zero for up to 12 months for eligible patients.
5. Uninsured or savings-card-ineligible patients: consider 503A compounded formulation. Prescribe to a licensed Oregon 503A pharmacy. Monitor TSH at 6 to 8 weeks.
6. All patients on any formulation change: recheck TSH at 6-8 weeks. Document the result and adjust dose if TSH is outside the patient's individualized target range.

Can I Get a Tirosint Prescription via Telehealth in Oregon?

Yes. Oregon law permits telehealth prescribing of Tirosint by licensed prescribers, including physicians, nurse practitioners, and physician assistants holding Oregon licensure. The prescriber must conduct a clinical evaluation sufficient to establish the diagnosis and clinical need, which can be done via synchronous video visit under Oregon's telehealth practice standards ORS 677.095.

HealthRX providers licensed in Oregon can evaluate patients, order thyroid labs (TSH, free T4, and anti-TPO antibodies where indicated), and prescribe Tirosint or compounded levothyroxine gel capsules during or immediately after the initial visit. Labs can be ordered to a patient-convenient draw location, and results are reviewed before the prescription is finalized.

Telehealth prescribing does not bypass the PA process for OHP patients. The PA must still be submitted through the OHP Preferred Drug List process, but the prescriber can initiate and manage that paperwork electronically without requiring the patient to come into a physical office.

Oregon's Ryan Haight Act compliance for telehealth prescribing of non-controlled substances (Tirosint is not a controlled substance) is straightforward: a valid prescriber-patient relationship established via telemedicine satisfies the standard-of-care requirement for this medication class.

What Is the Cheapest Way to Get Tirosint in Oregon?

The least expensive path depends on insurance status.

Oregon Health Plan members: The PA route is the best first step. Approved PA means Tirosint is covered at OHP cost-sharing rates, which for most OHP members is $0 to $3 per fill. Filing a strong PA with documented clinical rationale and relevant citations costs nothing except the prescriber's time.

Commercially insured patients: Apply the IBSA Tirosint Savings Card at the pharmacy counter. Eligible patients pay as little as $0 for up to 12 fills per year. If the savings card is not applicable (e.g., employer self-insured plans that opt out), ask the prescriber to appeal Tier 4 placement using the clinical data from Vita et al. and Benvenga et al. Successful tier exceptions can reduce the copay to Tier 2 or Tier 3 rates.

Uninsured or savings-card-ineligible patients: A licensed Oregon 503A compounding pharmacy is the most cost-effective option, with prices ranging from $15 to $40 per month. Patients should confirm the pharmacy's Oregon Board of Pharmacy license before filling.

Medicare Part D patients: Tirosint is not eligible for the IBSA savings card. Check the Extra Help (Low Income Subsidy) program through Social Security Administration if income qualifies. Some Part D plans place Tirosint on lower tiers with formulary exception letters from the prescriber; this requires documentation of medical necessity.

GoodRx coupons at Oregon pharmacies bring cash prices to approximately $195 to $210 for a 30-day supply at select locations, which is a modest improvement on the $230 WAC but far less impactful than insurance approval or the savings card.

Monitoring Tirosint Therapy: What Oregon Patients Should Expect

Starting or switching to Tirosint is not a set-and-forget event. TSH should be rechecked 6 to 8 weeks after initiation or any dose change. The ATA 2014 guidelines recommend a target TSH within the laboratory reference range (typically 0.5 to 4.5 mIU/L) for most adults, with individualized targets for pregnant patients, older adults, and those with cardiac disease Jonklaas et al., 2014.

Patients switching from levothyroxine tablets to Tirosint gel capsules may find their TSH shifts even if the dose in micrograms is identical. That happens because gel-capsule bioavailability can be modestly higher than tablet bioavailability in patients who previously had suboptimal tablet absorption. A dose adjustment of 12.5 to 25 mcg downward is occasionally needed in the first few months after switching.

Take Tirosint on an empty stomach, 30 to 60 minutes before breakfast, with water only. Calcium supplements, iron, antacids containing aluminum or magnesium, and PPIs should be spaced at least 4 hours from the Tirosint dose. These interactions apply to both the gel capsule and tablet forms, though the gel capsule appears more resilient to coffee-induced absorption interference based on the Benvenga 2013 data noted above.

Gel capsules should be stored at room temperature, 15 to 30 degrees Celsius, away from heat and moisture. Unlike Tirosint-SOL vials (which are single-use liquid ampules requiring no refrigeration but should not be used after opening), the gel capsules have a shelf life of approximately 24 months and do not require special storage conditions beyond a standard medicine cabinet.

Oregon patients receiving Tirosint via telehealth from HealthRX will receive automated TSH reminders at 6 weeks and 6 months post-initiation, with lab results reviewed by a licensed clinician before any dose adjustment is communicated.